Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 6, 2009, Pages 709-722

  Thomas, Rachael J ^a   Dumler, J Stephen ^b   Carlyon, Jason A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaplasma phagocytophilum; Anaplasmosis; Diagnosis; Ehrlichia chaffeensis; Ehrlichia ewingii; Human ehrlichiosis; Human granulocytic anaplasmosis; Human monocytic ehrlichiosis treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DOXYCYCLINE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANAMNESIS; ANAPLASMA PHAGOCYTOPHILUM; ANTIBODY DETECTION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BLOOD SMEAR; CLINICAL FEATURE; COMMUNITY ECOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EHRLICHIA EWINGII; EHRLICHIA EWINGII EHRLICHIOSIS; EHRLICHIOSIS; GENE AMPLIFICATION; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; HUMAN MONOCYTIC EHRLICHIOSIS; LABORATORY DIAGNOSIS; NONHUMAN; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; SERODIAGNOSIS; TREATMENT DURATION; ANIMAL; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MONOCYTE; NEUTROPHIL; PARASITE VECTOR; PATHOGENICITY; PATHOPHYSIOLOGY; TICK;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; ANTI-BACTERIAL AGENTS; ARACHNID VECTORS; DOXYCYCLINE; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; HUMANS; IXODIDAE; MONOCYTES; NEUTROPHILS;

EID: 70350468702     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/ERI.09.44     Document Type: Review

References (139)

1. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol. 29(12), 2838-2842 (1991). • Represents the discovery of Ehrlichia chaffeensis as a causative agent of human monocytic ehrlichiosis.
2. Buller RS, Arens M, Hmiel SP et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N. Engl. J. Med. 341(3), 148-155 (1999). • First report of Ehrlichia ewingii infection in humans.
3. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32(3), 589-595 (1994). • Initial identification of what would eventually be named Anaplasma phagocytophilum as the causative agent of human granulocytic anaplasmosis (formerly human granulocytic ehrlichiosis).
4. Foggie A. Studies on the infectious agent of tick-borne fever and sheep. J. Pathol. Bacteriol. 63, 1-15 (1951).
5. Gribble DH. Equine ehrlichiosis. J. Am. Vet. Med. Assoc. 155, 462-469 (1969).
6. Dumler JS, Barbet AF, Bekker CP et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51(Pt 6), 2145-2165. (2001).
7. Maeda K, Markowitz N, Hawley RC et al. Human infection with Ehrlichia canis, a leukocytic rickettsia. N. Engl. J. Med. 316(14), 853-856 (1987). (Pubitemid 17042004)
8. Perez M, Rikihisa Y, Wen B. Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J. Clin. Microbiol. 34(9), 2133-2139 (1996). (Pubitemid 26272191)
9. Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann. NY Acad. Sci. 1078, 110-117 (2006). (Pubitemid 46001339)
10. Dawson JE, Ewing SA, Davidson WR et al. Human monocytotrophic Ehrlichiosis. In: Tick-Borne Diseases of Humans. Goodman JL, Dennis DT, Sonenshine DE (Eds.) ASM Press, Washington, DC, USA 239-257 (2005). •• Excellent review of the history, ecology, epidemiology, pathobiology, diagnosis and treatment of human monocytic ehrlichiosis.
11. Chapman AS, Bakken JS, Folk SM et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm. Rep. 55(RR-4), 1-27 (2006). •• Indispensible guide for physicians and healthcare professionals on clinical diagnosis of tick-borne rickettsial diseases as well as patient management of such illnesses.
12. Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin. Microbiol. Rev. 16(1), 37-64 (2003).
13. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet. Res. 36(3), 469-492 (2005). (Pubitemid 40718654)
14. Long SW, Zhang X, Zhang J et al. Evaluation of transovarial transmission and transmissibility of Ehrlichia chaffeensis (Rickettsiales: Anaplasmataceae) in Amblyomma americanum (Acari: Ixodidae). J. Med. Entomol. 40(6), 1000-1004 (2003). (Pubitemid 38105846)
15. Paddock CD, Yabsley MJ. Ecological havoc, the rise of white-tailed deer, and the emergence of Amblyomma americanum-associated zoonoses in the United States. Curr. Top. Microbiol. Immunol. 315, 289-324 (2007).
16. Kawahara M, Rikihisa Y, Lin Q et al. Novel genetic variants of Anaplasma phagocytophilum, Anaplasma bovis, Anaplasma centrale, and a novel Ehrlichia sp. in wild deer and ticks on two major islands in Japan. Appl. Environ. Microbiol. 72(2), 1102-1109 (2006). (Pubitemid 43273481)
17. Machado RZ, Duarte JM, Dagnone AS, Szabo MP. Detection of Ehrlichia chaffeensis in Brazilian marsh deer (Blastocerus dichotomus). Vet. Parasitol. 139(1-3), 262-266 (2006).
18. Lee M, Yu D, Yoon J et al. Natural co-infection of Ehrlichia chaffeensis and Anaplasma bovis in a deer in South Korea. J. Vet. Med. Sci. 71(1), 101-103 (2009).
19. Ewing SA, Johnson EM, Kocan KM. Human infection with Ehrlichia canis. N. Engl. J. Med. 317(14), 899-900 (1987).
20. Notifiable diseases/deaths in selected cities weekly information. Morb. Mortal. Wkly Rep. 57(52), 1396-1407 (2009).
21. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann. Intern. Med. 120(9), 736-743 (1994).
22. Gardner SL, Holman RC, Krebs JW, Berkelman R, Childs JE. National surveillance for the human ehrlichioses in the United States, 1997-2001, and proposed methods for evaluation of data quality. Ann. NY Acad. Sci. 990, 80-89 (2003).
23. Demma LJ, Holman RC, McQuiston JH, Krebs JW, Swerdlow DL. Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am. J. Trop. Med. Hyg. 73(2), 400-409 (2005).
24. Heo EJ, Park JH, Koo JR et al. Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. J. Clin. Microbiol. 40(8), 3082-3085 (2002).
25. Moro PL, Shah J, Li O et al. Short report: serologic evidence of human ehrlichiosis in Peru. Am. J. Trop. Med. Hyg. 80(2), 242-244 (2009).
26. Uhaa IJ, MacLean JD, Greene CR, Fishbein DB. A case of human ehrlichiosis acquired in Mali: clinical and laboratory findings. Am. J. Trop. Med. Hyg. 46(2), 161-164 (1992).
27. Goodman JL. Human granulocytic anaplasmosis. In: Tick-Borne Diseases of Humans. Goodman JL, Dennis DT, Sonenshine DE (Eds.) ASM Press, Washington, DC, USA 218-238 (2005). •• Excellent review of the history, ecology, epidemiology, pathobiology, diagnosis and treatment of human granulocytic anaplasmosis.
28. Magnarelli LA, Stafford KC 3rd, Mather TN et al. Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J. Clin. Microbiol. 33(10), 2710-2714 (1995).
29. Pancholi P, Kolbert CP, Mitchell PD et al. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J. Infect. Dis. 172(4), 1007-1012 (1995).
30. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin. Microbiol. Infect. 8(12), 763-772 (2002).
31. Cao WC, Zhao QM, Zhang PH et al. Granulocytic Ehrlichiae in Ixodes persulcatus ticks from an area in China where Lyme disease is endemic. J. Clin. Microbiol. 38(11), 4208-4210 (2000).
32. Cinco M, Padovan D, Murgia R et al. Coexistence of Ehrlichia phagocytophila and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Italy as determined by 16S rRNA gene sequencing. J. Clin. Microbiol. 35(12), 3365-3366 (1997). (Pubitemid 27505789)
33. Piccolin G, Benedetti G, Doglioni C et al. A study of the presence of B. burgdorferi, Anaplasma (previously Ehrlichia) phagocytophilum, Rickettsia, and Babesia in Ixodes ricinus collected within the territory of Belluno, Italy. Vector Borne Zoonotic Dis. 6(1), 24-31 (2006).
34. Mantelli B, Pecchioli E, Hauffe HC, Rosa R, Rizzoli A. Prevalence of Borrelia burgdorferi s.l. and Anaplasma phagocytophilum in the wood tick Ixodes ricinus in the Province of Trento, Italy. Eur. J. Clin. Microbiol. Infect. Dis. 25(11), 737-739 (2006). (Pubitemid 44806785)
35. Alberdi MP, Walker AR, Paxton EA, Sumption KJ. Natural prevalence of infection with Ehrlichia (Cytoecetes) phagocytophila of Ixodes ricinus ticks in Scotland. Vet. Parasitol. 78(3), 203-213 (1998).
36. Parola P, Beati L, Cambon M, Brouqui P, Raoult D. Ehrlichia DNA amplified from Ixodes ricinus (Acari: Ixodidae) in France. J. Med. Entomol. 35(2), 180-183 (1998). (Pubitemid 128460058)
37. Halos L, Vourc'h G, Cotte V et al. Prevalence of Anaplasma phagocytophilum, Rickettsia sp. and Borrelia burgdorferi sensu lato DNA in questing Ixodes ricinus ticks from France. Ann. NY Acad. Sci. 1078, 316-319 (2006). (Pubitemid 44968636)
38. Petrovec M, Sumner JW, Nicholson WL et al. Identity of Ehrlichia DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J. Clin. Microbiol. 37(1), 209-210 (1999). (Pubitemid 29004209)
39. Liz JS, Anderes L, Sumner JW et al. PCR detection of granulocytic Ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J. Clin. Microbiol. 38(3), 1002-1007 (2000). (Pubitemid 30140550)
40. Pusterla N, Leutenegger CM, Huder JB et al. Evidence of the human granulocytic ehrlichiosis agent in Ixodes ricinus ticks in Switzerland. J. Clin. Microbiol. 37(5), 1332-1334 (1999). (Pubitemid 29187794)
41. Schouls LM, Van De Pol I, Rijpkema SG, Schot CS. Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella species in Dutch Ixodes ricinus ticks. J. Clin. Microbiol. 37(7), 2215-2222 (1999). (Pubitemid 29277782)
42. Skarphedinsson S, Lyholm BF, Ljungberg M et al. Detection and identification of Anaplasma phagocytophilum, Borrelia burgdorferi, and Rickettsia helvetica in Danish Ixodes ricinus ticks. Apmis 115(3), 225-230 (2007). (Pubitemid 46437128)
43. Fingerle V, Munderloh UG, Liegl G, Wilske B. Coexistence of Ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from Southern Germany. Med. Microbiol. Immunol. 188(3), 145-149 (1999). (Pubitemid 30085361)
44. Baumgarten BU, Rollinghoff M, Bogdan C. Prevalence of Borrelia burgdorferi and granulocytic and monocytic Ehrlichiae in Ixodes ricinus ticks from southern Germany. J. Clin. Microbiol. 37(11), 3448-3451 (1999). (Pubitemid 29491072)
45. Christova IS, Dumler JS. Human granulocytic ehrlichiosis in Bulgaria. Am. J. Trop. Med. Hyg. 60(1), 58-61 (1999).
46. Oteo JA, Gil H, Barral M et al. Presence of granulocytic Ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol. Infect. 127(2), 353-358 (2001). (Pubitemid 33019548)
47. Alekseev AN, Dubinina HV, Semenov AV, Bolshakov CV. Evidence of ehrlichiosis agents found in ticks (Acari: Ixodidae) collected from migratory birds. J. Med. Entomol. 38(4), 471-474 (2001).
48. Chmielewska-Badora J, Zwolinski J, Cisak E et al. Prevalence of Anaplasma phagocytophilum in Ixodes ricinus ticks determined by polymerase chain reaction with two pairs of primers detecting 16S rRNA and ankA genes. Ann. Agric. Environ. Med. 14(2), 281-285 (2007). (Pubitemid 351286160)
49. Grzeszczuk A, Stanczak J. Highly variable year-to-year prevalence of Anaplasma phagocytophilum in Ixodes ricinus ticks in northeastern Poland: a 4-year follow-up. Ann. NY Acad. Sci. 1078, 309-311 (2006). (Pubitemid 44968634)
50. Grzeszczuk A. Anaplasma phagocytophilum in Ixodes ricinus ticks and human granulocytic anaplasmosis seroprevalence among forestry rangers in Bialystok region. Adv. Med. Sci. 51, 283-286 (2006).
51. Bown KJ, Begon M, Bennett M et al. Sympatric Ixodes trianguliceps and Ixodes ricinus ticks feeding on field voles (Microtus agrestis): potential for increased risk of Anaplasma phagocytophilum in the United Kingdom? Vector Borne Zoonotic Dis. 6(4), 404-410 (2006). (Pubitemid 46157523)
52. Bown KJ, Lambin X, Telford GR et al. Relative importance of Ixodes ricinus and Ixodes trianguliceps as vectors for Anaplasma phagocytophilum and Babesia microti in field vole (Microtus agrestis) populations. Appl. Environ. Microbiol. 74(23), 7118-7125 (2008). (Pubitemid 352773567)
53. Santos AS, Santos-Silva MM, Almeida VC, Bacellar F, Dumler JS. Detection of Anaplasma phagocytophilum DNA in Ixodes ticks (Acari: Ixodidae) from Madeira Island and Setubal District, mainland Portugal. Emerg. Infect. Dis. 10(9), 1643-1648 (2004). (Pubitemid 39206311)
54. Santos AS, Santos-Silva MM, Sousa RD, Bacellar F, Dumler JS. PCR-Based Survey of Anaplasma phagocytophilum in Portuguese ticks (Acari: Ixodidae). Vector Borne Zoonotic Dis. (2008).
55. Burgdorfer W, Barbour AG, Hayes SF et al. Lyme disease - a tick-borne spirochetosis? Science 216(4552), 1317-1319 (1982).
56. Spielman A, Clifford CM, Piesman J, Corwin MD. Human babesiosis on Nantucket Island, USA: description of the vector, Ixodes (Ixodes) dammini, n. sp. (Acarina: Ixodidae). J. Med. Entomol. 15(3), 218-234 (1979). (Pubitemid 9145023)
57. Nuttal PA, Labuda M. Tick-born encephalitis. In: Tick-Borne Diseases of Humans. Goodman JL, Dennis DT, Sonenshine DE (Eds.) ASM Press, Washington, DC, USA 150-163 (2005).
58. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Strle F. Concomitant tickborne encephalitis and human granulocytic ehrlichiosis. Emerg. Infect. Dis. 11(3), 485-488 (2005). (Pubitemid 40315744)
59. Nieto NC, Foley JE. Meta-analysis of coinfection and coexposure with Borrelia burgdorferi and Anaplasma phagocytophilum in humans, domestic animals, wildlife, and Ixodes ricinus-complex ticks. Vector Borne Zoonotic Dis. 9, 93-102 (2008).
60. Skotarczak B, Rymaszewska A, Wodecka B, Sawczuk M. Molecular evidence of coinfection of Borrelia burgdorferi sensu lato, human granulocytic ehrlichiosis agent, and Babesia microti in ticks from northwestern Poland. J. Parasitol. 89(1), 194-196 (2003). (Pubitemid 36284711)
61. Telford SR 3rd, Dawson JE, Katavolos P et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl Acad. Sci. USA 93(12), 6209-6214 (1996).
62. Nieto NC, Foley JE. Evaluation of squirrels (Rodentia: Sciuridae) as ecologically significant hosts for Anaplasma phagocytophilum in California. J. Med. Entomol. 45(4), 763-769 (2008).
63. Foley JE, Clueit SB, Brown RN. Differential exposure to Anaplasma phagocytophilum in rodent species in northern California. Vector Borne Zoonotic Dis. 8(1), 49-55 (2008).
64. Foley JE, Nieto NC, Clueit SB et al. Survey for zoonotic rickettsial pathogens in northern flying squirrels, Glaucomys sabrinus, in California. J. Wildl. Dis. 43(4), 684-689 (2007).
65. Nieto NC, Foley JE. Reservoir competence of the Redwood chipmunk (Tamias ochrogenys) for Anaplasma phagocytophilum. Vector Borne Zoonotic Dis. DOI: 10.1089/vbz.2008.0142 (2008) (Epub ahead of print).
66. Foley J, Nieto NC, Madigan J, Sykes J. Possible differential host tropism in Anaplasma phagocytophilum strains in the Western United States. Ann. NY Acad. Sci. 1149, 94-97 (2008).
67. Levin ML, Nicholson WL, Massung RF, Sumner JW, Fish D. Comparison of the reservoir competence of medium-sized mammals and Peromyscus leucopus for Anaplasma phagocytophilum in Connecticut. Vector Borne Zoonotic Dis. 2(3), 125-136 (2002).
68. Belongia EA, Reed KD, Mitchell PD et al. Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin. J. Clin. Microbiol. 35(6), 1465-1468 (1997).
69. Massung RF, Slater K, Owens JH et al. Nested PCR assay for detection of granulocytic Ehrlichiae. J. Clin. Microbiol. 36(4), 1090-1095 (1998). (Pubitemid 28146303)
70. Massung RF, Mather TN, Priestley RA, Levin ML. Transmission efficiency of the AP-variant 1 strain of Anaplasma phagocytophila. Ann. NY Acad. Sci. 990, 75-79 (2003).
71. Reichard MV, Roman RM, Kocan KM et al. Inoculation of white-tailed deer (Odocoileus virginianus) with Ap-V1 Or NY-18 strains of Anaplasma phagocytophilum and microscopic demonstration of Ap-V1 In Ixodes scapularis adults that acquired infection from deer as nymphs. Vector Borne Zoonotic Dis. DOI: 10.1089/vbz.2008.0106 (2008) (Epub ahead of print).
72. Petrovec M, Sixl W, Schweiger R et al. Infections of wild animals with Anaplasma phagocytophila in Austria and the Czech Republic. Ann. NY Acad. Sci. 990, 103-106 (2003). (Pubitemid 36808286)
73. Brouqui P. Ehrlichiosis in Europe. In: Rickettsiae and Rickettsial Diseases at the Turn of the Third Millenium. Raoult D, Brouqui P (Eds.) Elsevier, Paris, France 220-232 (1999).
74. Bakken JS, Dumler JS, Chen SM et al. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 272(3), 212-218 (1994).
75. Ijdo JW, Meek JI, Cartter ML et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J. Infect. Dis. 181(4), 1388-1393 (2000).
76. Bakken JS, Krueth J, Wilson-Nordskog C et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275(3), 199-205 (1996). (Pubitemid 26386130)
77. Standaert SM, Yu T, Scott MA et al. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J. Infect. Dis. 181(3), 1082-1088 (2000). (Pubitemid 30194495)
78. Olano JP, Masters E, Hogrefe W, Walker DH. Human monocytotropic ehrlichiosis, Missouri. Emerg. Infect. Dis. 9(12), 1579-1586 (2003).
79. Bakken JS, Goellner P, Van Etten M et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin. Infect. Dis. 27(6), 1491-1496 (1998). (Pubitemid 29242427)
80. Standaert SM, Dawson JE, Schaffner W et al. Ehrlichiosis in a golf-oriented retirement community. N. Engl. J. Med. 333(7), 420-425 (1995).
81. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet 346(8977), 782-783 (1995).
82. Petrovec M, Lotric Furlan S, Zupanc TA et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J. Clin. Microbiol. 35(6), 1556-1559 (1997). (Pubitemid 27216832)
83. van Dobbenburgh A, van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe. N. Engl. J. Med. 340(15), 1214-1216 (1999). (Pubitemid 29177888)
84. Oteo JA, Blanco JR, Martinez de Artola V, Ibarra V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg. Infect. Dis. 6(4), 430-432 (2000). (Pubitemid 30643675)
85. Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis - a clinical case in Scandinavia. Scand. J. Infect. Dis. 33(1), 73-74 (2001). (Pubitemid 32156735)
86. Bjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I. Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented. Lakartidningen 96(39), 4200-4204 (1999).
87. Misic-Majerus L, Bujic N, Madaric V, Avsic-Zupanc T, Milinkovic S. Human anaplasmosis (ehrlichiosis). Acta Med. Croatica 60(5), 411-419 (2006).
88. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M et al. First cases of acute human granulocytic ehrlichiosis in Poland. Eur. J. Clin. Microbiol. Infect. Dis. 20(3), 196-198 (2001). (Pubitemid 32375133)
89. Chochlakis D, Papaeustathiou A, Minadakis G, Psaroulaki A, Tselentis Y. A serosurvey of Anaplasma phagocytophilum in blood donors in Crete, Greece. Eur. J. Clin. Microbiol. Infect. Dis. 27(6), 473-475 (2008).
90. Bakken JS, Dumler S. Human granulocytic anaplasmosis. Infect. Dis. Clin. North Am. 22(3), 433-448, viii (2008).
91. Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin. Infect. Dis. 45(Suppl. 1), S45-S51 (2007). (Pubitemid 47036025)
92. Sreter T, Sreter-Lancz Z, Szell Z, Kalman D. Anaplasma phagocytophilum: an emerging tick-borne pathogen in Hungary and Central Eastern Europe. Ann. Trop. Med. Parasitol. 98(4), 401-405 (2004). (Pubitemid 38903484)
93. Portillo A, Santos AS, Santibanez S et al. Detection of a non-pathogenic variant of Anaplasma phagocytophilum in Ixodes ricinus from La Rioja, Spain. Ann. NY Acad. Sci. 1063, 333-336 (2005).
94. Anderson BE, Greene CE, Jones DC, Dawson JE. Ehrlichia ewingii sp. nov., the etiologic agent of canine granulocytic ehrlichiosis. Int. J. Syst. Bacteriol. 42(2), 299-302 (1992).
95. Paddock CD, Liddell AM, Storch GA. Other causes of tick-borne ehrlichioses, including Ehrlichia ewingii. In: Tick-Borne Diseases of Humans. Goodman JL, Dennis DT, Sonenshine DE (Eds.) ASM Press, Washington, DC, USA (2005). •• Excellent review of the history, ecology, epidemiology, pathobiology, diagnosis and treatment of human E. ewingii ehrlichiosis and other tick-borne infections.
96. Wolf L, McPherson T, Harrison B et al. Prevalence of Ehrlichia ewingii in Amblyomma americanum in North Carolina. J. Clin. Microbiol. 38(7), 2795 (2000). (Pubitemid 30485179)
97. Anziani OS, Ewing SA, Barker RW. Experimental transmission of a granulocytic form of the tribe Ehrlichieae by Dermacentor variabilis and Amblyomma americanum to dogs. Am. J. Vet. Res. 51(6), 929-931 (1990).
98. Yabsley MJ, Varela AS, Tate CM et al. Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus). Emerg. Infect. Dis. 8(7), 668-671 (2002).
99. Centers for Disease Control and Prevention (CDC). Anaplasma phagocytophilum transmitted through blood Transfusion - Minnesota, 2007. Morb. Mortal. Wkly Rep. 57(42), 1145-1148 (2008). • First report of transmission of A. phagocytophilum via blood transfusion.
100. Zhang L, Liu Y, Ni D et al. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 300(19), 2263-2270 (2008). • Represents the first possible case of nosocomial transmission of human granulocytic anaplasmosis.
101. Krause PJ, Wormser GP. Nosocomial transmission of human granulocytic anaplasmosis? JAMA 300(19), 2308-2309 (2008). • Expert commentary on the report by Zhang and colleagues.
102. Gardner T. Lyme Disease. In: Infectious Diseases of the Fetus and Newborn Infant. Remmington JS, Klein JO (Eds). WB Saunders, PA, USA 447-528 (1995) .
103. Horowitz HW, Kilchevsky E, Haber S et al. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 339(6), 375-378 (1998). (Pubitemid 28363800)
104. Stamp JT, Watt JA, Jamieson S. Tick-borne fever as a cause of abortion in sheep. Vet. Rec. 62(32), 465-470 (1950).
105. Cranwell MP, Gibbons JA. Tick-borne fever in dairy herd. Vet. Rec. 119(21), 531-532 (1986).
106. Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin. Microbiol. Infect. 10(12), 1108-1132 (2004). •• Comprehensive guide to the diagnosis of bacterial tick-borne infections compiled by the European Society of Clinical Microbiology of Infectious Diseases Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella in conjunction with the European Network for Surveillance of Tick-Borne Diseases.
107. Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43(9), 1089-1134 (2006). •• Compendious review compiled by an expert panel of the Infectious Diseases Society of America outlining the clinical guidelines assessing and managing tick-borne infections in the USA.
108. Bakken JS, Haller I, Riddell D, Walls JJ, Dumler JS. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin. Infect. Dis. 34(1), 22-27 (2002). (Pubitemid 33152661)
109. Dumler JS, Choi KS, Garcia-Garcia JC et al. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg. Infect. Dis. 11(12), 1828-1834 (2005).
110. Fishbein DB, Kemp A, Dawson JE et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J. Infect. Dis. 160(5), 803-809 (1989). (Pubitemid 19266836)
111. Standaert SM, Clough LA, Schaffner W, Adams JS, Neuzil KM. Neurologic manifestations of human monocytic ehrlichiosis. Infect. Dis. Clin. Prac. 7(7), 358-362 (1998). (Pubitemid 28421685)
112. Paddock CD, Folk SM, Shore GM et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin. Infect. Dis. 33(9), 1586-1594 (2001).
113. Bakken JS, Dumler JS. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann. NY Acad. Sci. 1078, 236-247 (2006).
114. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31(2), 554-560 (2000).
115. Doyle CK, Labruna MB, Breitschwerdt EB et al. Detection of medically important Ehrlichia by quantitative multicolor TaqMan real-time polymerase chain reaction of the dsb gene. J. Mol. Diagn. 7(4), 504-510 (2005).
116. Bell CA, Patel R. A real-time combined polymerase chain reaction assay for the rapid detection and differentiation of Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Ehrlichia ewingii. Diagn. Microbiol. Infect. Dis. 53(4), 301-306 (2005). (Pubitemid 41796902)
117. Goodman JL, Nelson C, Vitale B et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334(4), 209-215 (1996). • Represents the first report of cultivation of A. phagocytophilum in mammalian tissue culture, which has been critical for all subsequent in vitro studies of the pathobiology of this bacterium.
118. Carlyon JA. Laboratory Maintenance of Anaplasma phagocytophilum. Curr. Protoc. Microbiol. Chapter 3, Unit 3A 2 (2005). • Comprehensive chapter on maintaining and studying A. phagocytophilum in the laboratory.
119. Walls JJ, Aguero-Rosenfeld M, Bakken JS et al. Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J. Clin. Microbiol. 37(9), 2968-2973 (1999). (Pubitemid 29391918)
120. Walker DH. Ehrlichioses TFoCAf. Diagnosing human ehrlichioses: current status and recommendations. ASM News 66, 287-290 (2000).
121. Dawson JE, Fishbein DB, Eng TR, Redus MA, Green NR. Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test: kinetics and specificity. J. Infect. Dis. 162(1), 91-95 (1990).
122. Rikihisa Y, Ewing SA, Fox JC. Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans. J. Clin. Microbiol. 32(9), 2107-2112 (1994). (Pubitemid 24258449)
123. Yevich SJ, Sanchez JL, DeFraites RF et al. Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J. Infect. Dis. 171(5), 1266-1273 (1995).
124. Wallman IS, Hilton HB. Teeth pigmented by tetracycline. Lancet 1(7234), 827-829 (1962).
125. Grossman ER, Walchek A, Freedman H. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 47(3), 567-570 (1971).
126. Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr. Infect. Dis. J. 17(5), 429-431 (1998).
127. Pediatrics AAo. Ehrlichia infections (human ehrlichioses). In: 2003 Red Book: Report of the Committee on Infectious Diseases. Pickering L, Baker C, Overturf G, Prober C (Eds). American Academy of Pediatrics, Committee on Inffectious Diseases, Elk Grove Village, IL, USA 266-269 (2003).
128. Smith Sehdev AE, Sehdev PS, Jacobs R, Dumler JS. Human monocytic ehrlichiosis presenting as acute appendicitis during pregnancy. Clin. Infect. Dis. 35(9), e99-e102 (2002).
129. Buitrago MI, Ijdo JW, Rinaudo P et al. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin. Infect. Dis. 27(1), 213-215 (1998). (Pubitemid 28334446)
130. Elston DM. Perinatal transmission of human granulocytic ehrlichiosis. N. Engl. J. Med. 339(26), 1941-1942; author reply 1942-1943 (1998).
131. Krause PJ, Corrow CL, Bakken JS. Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 112(3 Pt 1), e252-253 (2003).
132. Klein MB, Nelson CM, Goodman JL. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob. Agents Chemother. 41(1), 76-79 (1997).
133. Maurin M, Bakken JS, Dumler JS. Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob. Agents Chemother. 47(1), 413-415 (2003). (Pubitemid 36074933)
134. Wormser GP, Filozov A, Telford SR 3rd et al. Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis. Vector Borne Zoonotic Dis. 6(4), 388-394 (2006). • Report indicating that levofloxacin is not effective in curing human granulocytic anaplasmosis. (Pubitemid 46157521)
135. Brouqui P, Raoult D. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 36(12), 2799-2803 (1992).
136. Carroll JF, Klun JA, Debboun M. Repellency of deet and SS220 applied to skin involves olfactory sensing by two species of ticks. Med. Vet. Entomol. 19(1), 101-106 (2005). (Pubitemid 40398706)
137. Lane RS. Treatment of clothing with a permethrin spray for personal protection against the Western black-legged tick, Ixodes pacificus (Acari: Ixodidae). Exp. Appl. Acarol. 6(4), 343-352 (1989).
138. Piesman J, Eisen L. Prevention of tick-borne diseases. Annu. Rev. Entomol. 53, 323-343 (2008).
139. Gardulf A, Wohlfart I, Gustafson R. A prospective cross-over field trial shows protection of lemon eucalyptus extract against tick bites. J. Med. Entomol. 41(6), 1064-1067 (2004). (Pubitemid 39606429)